Heteroresistance to cefepime-taniborbactam in metallo-β-lactamase-encoding Enterobacterales
- PMID: 37421967
- DOI: 10.1016/S1473-3099(23)00426-7
Heteroresistance to cefepime-taniborbactam in metallo-β-lactamase-encoding Enterobacterales
Conflict of interest statement
CA and DSW conceived the study and CA performed all experiments. CA, SWS, and DSW conferred on study design and data analysis. CA wrote the manuscript with assistance from SWS and DSW. This Correspondence was funded by NIH grants (grant number AI158080 to SWS and DSW and grant number AI148661 to DSW). DSW was also funded by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease award. The funders had no role in the study. DSW has pending patents related to heteroresistance. All other authors declare no competing interests.
Comment on
-
NDM-9 resistance to taniborbactam.Lancet Infect Dis. 2023 Apr;23(4):401-402. doi: 10.1016/S1473-3099(23)00069-5. Epub 2023 Feb 13. Lancet Infect Dis. 2023. PMID: 36796395 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
